FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Jan. 31, 2025

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The Company's assets and liabilities that were measured at fair value on a recurring basis are set forth by level within the fair value hierarchy in the following tables (in thousands):

	As of January 31, 2025
	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)	Total
Assets:
Deferred compensation plan:
Corporate-owned life insurance	$—	$326,491	$—	$326,491
Money market fund	18,027	—	—	18,027
Total assets	$18,027	$326,491	$—	$344,518
Liabilities:
Contingent consideration	$—	$—	$36,514	$36,514

	As of October 31, 2024
	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)	Total
Assets:
Deferred compensation plan:
Corporate-owned life insurance	$—	$313,794	$—	$313,794
Money market fund	3,365	—	—	3,365
Total assets	$3,365	$313,794	$—	$317,159
Liabilities:
Contingent consideration	$—	$—	$30,207	$30,207

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

The following unobservable inputs were used to derive the estimated fair value of the Company's Level 3 contingent consideration liabilities as of January 31, 2025 ($ in thousands):

		Unobservable		Weighted
Acquisition Date	Fair Value	Input	Range	Average (1)
1-31-2025	$11,457	Compound annual revenue growth rate	5% - 22%	17%
		Discount rate	7.6% - 7.6%	7.6%
7-18-2022	22,697	Compound annual revenue growth rate	5% - 10%	9%
		Discount rate	7.6% - 7.6%	7.6%
3-17-2022	2,360	Compound annual revenue growth rate	1% - 5%	4%
		Discount rate	8.1% - 8.1%	8.1%

(1)    Unobservable inputs were weighted by the relative fair value of the contingent consideration liability.

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

Changes in the Company’s contingent consideration liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3) for the three months ended January 31, 2025 are as follows (in thousands):

	Liabilities
Balance as of October 31, 2024	$30,207
Contingent consideration related to an acquisition	11,457
Payment of contingent consideration	(8,144)
Increase in accrued contingent consideration	3,288
Foreign currency transaction adjustments	(294)
Balance as of January 31, 2025	$36,514